MCK Q3 2021 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q3 2021 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$62.6B+5.8% YoY

Gross Profit

$3.0B4.8% margin

Operating Income

$894M1.4% margin

Net Income

-$6.2B-9.9% margin

EPS (Diluted)

$-39.03

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$1.1B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.8B

Total Liabilities

$60.8B

Stockholders' Equity

-$477M

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62.6B	$59.2B	+5.8%
Gross Profit	$3.0B	$2.9B	+3.0%
Operating Income	$894M	$498M	+79.5%
Net Income	-$6.2B	$186M	-3447.3%

Revenue Segments

U.S. Pharmaceutical Segment

$49.5B79%

International Segment

$9.3B15%

Medical-Surgical Solutions Segment

$3.1B5%

Prescription Technology Solutions

$777M1%